Scinai Immunotherapeutics Stock Price Prediction

Intrinsic Valuation Low Real High 0.05 0.91 8.35 Details

Naive Forecast Low Next High 0.02 1.10 8.53 Details

1 Analysts Consensus Low Target High 637.00 700.00 777.00 Details

Scinai Immunotherapeuti After-Hype Price Density Analysis

Scinai Immunotherapeuti Estimiated After-Hype Price Volatility

Scinai Immunotherapeuti Stock Price Outlook Analysis

Notes

Scinai Immunotherapeuti Hype Timeline

Scinai Immunotherapeutics is at this time traded for 1.04. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.05. Scinai is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.26%. %. The volatility of related hype on Scinai Immunotherapeuti is about 4048.91%, with the expected price after the next announcement by competition of 0.99. The company has price-to-book ratio of 1.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Scinai Immunotherapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 21st of May 2024. Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Scinai Immunotherapeuti Basic Forecasting Models to cross-verify your projections.

Scinai Immunotherapeuti Related Hype Analysis

Scinai Immunotherapeuti Additional Predictive Modules

Most predictive techniques to examine Scinai price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Scinai using various technical indicators. When you analyze Scinai charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Scinai Immunotherapeuti stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Scinai Immunotherapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Scinai Immunotherapeuti based on analysis of Scinai Immunotherapeuti hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Scinai Immunotherapeuti's price analysis, check to measure Scinai Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scinai Immunotherapeuti is operating at the current time. Most of Scinai Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Scinai Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scinai Immunotherapeuti's price. Additionally, you may evaluate how the addition of Scinai Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.